Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
Journal Information
Full Title: Rheumatol Int
Abbreviation: Rheumatol Int
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of InterestAR: Honoraria for lectures/presentations from MSD&Lilly and support for attending meetings from Abbvie; NA: Honoraria for lectures/presentations from Abbvie, Pfizer&Lilly and support for attending meetings from Abbvie, MSD&Pfizer; GB: Consulting fees from AstraZeneca&GS, and honoraria for lectures/presentations from Pfizer, Novartis, UCB, Aenorasis&GSK; PS: Research grants from Pfizer, MSD, Abbvie, Lilly, Novartis, Amgen, consulting fees from Abbvie, Pfizer, Lilly; IF, AB, AE, SP, EK, MT: No conflicts of interest. Ethical ApprovalThis study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was obtained from the Institutional Review-Board of the University Hospital of Heraklion, Crete (decision-number:1476/20-03-2012). Consent to participate and to publishWritten informed consent was obtained from all participants included in the study regarding their participation and publishing of anonymized data. Conflict of Interest AR: Honoraria for lectures/presentations from MSD&Lilly and support for attending meetings from Abbvie; NA: Honoraria for lectures/presentations from Abbvie, Pfizer&Lilly and support for attending meetings from Abbvie, MSD&Pfizer; GB: Consulting fees from AstraZeneca&GS, and honoraria for lectures/presentations from Pfizer, Novartis, UCB, Aenorasis&GSK; PS: Research grants from Pfizer, MSD, Abbvie, Lilly, Novartis, Amgen, consulting fees from Abbvie, Pfizer, Lilly; IF, AB, AE, SP, EK, MT: No conflicts of interest."
"Funding Open access funding provided by HEAL-Link Greece. This study has been supported by the "Pancretan Health Organization” and also through a Pfizer Research Grant (ID number 55999165). Neither of the two funders had a role in study design, collection, analysis and interpretation of the data, in the writing of the manuscript and in the decision to submit the manuscript for publication."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025